Sinopep Allsino Bio Pharmaceutical Co Ltd Class A 688076
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥27.84
- Day Range
- CN¥28.00–28.64
- 52-Week Range
- CN¥25.70–41.17
- Bid/Ask
- CN¥28.08 / CN¥28.09
- Shares Outstanding
- 316.82M
- Market Cap
- CN¥8.90B
- Volume/Avg
- 2M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 32.52
- Price/Sales
- 4.36
- Dividend Yield (Trailing)
- 1.25%
- Dividend Yield (Forward)
- 1.25%
- Dividend Payment Schedule
- Jun
- Total Yield
- 1.25%
Company Profile
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,360
- Website
- http://www.sinopep.com.cn
Valuation
|
Metric
|
688076
|
|---|---|
Price/Earnings (Normalized) | 32.52 |
Price/Book Value | 2.88 |
Price/Sales | 4.36 |
Price/Cash Flow | 10.37 |
Price/Earnings
688076
Financial Strength
|
Metric
|
688076
|
|---|---|
Quick Ratio | 0.69 |
Current Ratio | 1.14 |
Interest Coverage | 4.15 |
Quick Ratio
688076
Profitability
|
Metric
|
688076
|
|---|---|
Return on Assets (Normalized) | 4.71% |
Return on Equity (Normalized) | 10.26% |
Return on Invested Capital (Normalized) | 6.73% |
Return on Assets
688076
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|n&s#vx? | LOCK|^?&$ | $127B | |||
| Moderna Inc
MRNA
| LOCK|b!@tj?V | LOCK|Glj | $87B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|&@?^HN | LOCK|WqR? | $81B | |||
| argenx SE ADR
ARGX
| LOCK|pWrws? | LOCK|Jq$ | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|B?#nwNk | LOCK|>S | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|>NvqZG& | LOCK|m&WMR | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|P<$r?!t | LOCK|>@%x# | $27B | |||
| Incyte Corp
INCY
| LOCK|>%P$%#G | LOCK|%wF | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|>$@$C$$ | LOCK|^x@ | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|rbx$%ht | LOCK|Lm> | $14B |
United States